Diane

“hydroxychloroquine in other countries, early-use outpatient treatment would be an important key to interrupting the exponential spread of the virus and minimizing deaths in the United States.)* Nonetheless, five days later, those very same FDA bureaucrats—including FDA commissioner Stephen Hahn and his eventual replacement, Janet Woodcock—completely countermanded the POTUS-Azar-Kadlec order. Instead, on March 28, the FDA issued a rogue directive restricting the use of hydroxychloroquine to the late treatment of hospitalized patients.13”
― Peter Navarro, In Trump Time: A Journal of America's Plague Year